Type 2 diabetes is one of the most common chronic conditions we see in older adults—and one of the most manageable when ...

A daily pill for Type 2 diabetes and weight loss is one step closer to transforming lives. Drug-maker Eli Lilly plans to seek regulatory approval for a GLP-1 pill for weight loss this year. The ...

A review of 17 studies reports a fourfold increase in risk and ties worse hearing to longer disease duration and higher HbA1c ...

New research highlights strength training as a powerful tool for managing type 2 diabetes. Lifting weights boosts insulin sensitivity, aids muscle growth for better glucose utilization, and helps ...

Managing blood sugar doesn't demand drastic changes; small daily habits offer significant support. Experts highlight that ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise. The FDA today ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Orforglipron conferred HbA1c reductions of 1.3 to 1.6 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Cumulative incidence of noncommunicable diseases was ...

Once-daily, oral SGLT2 inhibitor shown to reduce blood sugar and improve glycemic control as an adjunct to diet and exercise MARLBOROUGH, Mass.--(BUSINESS WIRE)--TheracosBio today announced that the U ...

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control in patients ages 10 and older with type 2 diabetes, used as an adjunct to ...

A sedentary lifestyle such as watching TV (two or more hours daily) may be a key factor in the risk of developing heart and blood vessel diseases, according to an analysis of health records from a ...